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Galline Ex-FABP was identified as another candidate
antibacterial, catecholate siderophore binding lipo-
calin (siderocalin) based on structural parallels with
the family archetype, mammalian Siderocalin.
Binding assays show that Ex-FABP retains iron in
a siderophore-dependent manner in both hypertro-
phic and dedifferentiated chondrocytes, where Ex-
FABP expression is induced after treatment with
proinflammatory agents, and specifically binds ferric
complexes of enterobactin, parabactin, bacillibactin
and, unexpectedly, monoglucosylated enterobactin,
which does not bind to Siderocalin. Growth arrest
assays functionally confirm the bacteriostatic effect
of Ex-FABP in vitro under iron-limiting conditions.
The 1.8 A˚ crystal structure of Ex-FABP explains the
expanded specificity, but also surprisingly reveals
an extended, multi-chambered cavity extending
through the protein and encompassing two separate
ligand specificities, one for bacterial siderophores
(as in Siderocalin) at one end and one specifically
binding copurified lysophosphatidic acid, a potent
cell signaling molecule, at the other end, suggesting
Ex-FABP employs dual functionalities to explain its
diverse endogenous activities.
INTRODUCTION
Galline Extracellular Fatty Acid Binding Protein (Ex-FABP) is
expressed in serum, egg whites, and granulocytes; Ex-FABP
mRNA is further found in several tissues including skin, brain,
heart, and kidney (Dozin et al., 1992; Gentili et al., 2005; Gue´-
rin-Dubiard et al., 2006). Ex-FABP is also secreted in large
amounts from hypertrophic chondrocytes and isolated
myoblasts during muscle fiber differentiation (Cancedda et al.,
1990; Dozin et al., 1992; Gentili et al., 2005; Manduca et al.,
1989). In adult chickens, Ex-FABP is expressed in response to
inflammation and tissue degeneration, such as osteoarthritis
and tibial dyschondroplasia (Cermelli et al., 2000). Ex-FABP1796 Structure 19, 1796–1806, December 7, 2011 ª2011 Elsevier Ltdhas previously been shown to: (1), affect cartilage and muscle
cell differentiation, heart development and embryonic survival;
and (2), selectively bind fatty acids like oleic, linoleic and arach-
idonic acid (Cancedda et al., 1996; Di Marco et al., 2003; Gentili
et al., 2005). However, the exact molecular mechanisms by
which Ex-FABP exerts these incongruent activities has not
been determined, nor is it understood how binding simple fatty
acids would affect these processes.
Ex-FABP belongs to the lipocalin family of proteins, many of
which bind fatty acids specifically or nonspecifically, but also
disparate ligands ranging from small molecules to proteins
(A˚kerstrom et al., 2000; Clifton et al., 2009). Despite the
confusing nomenclature, Ex-FABP is a lipocalin (Ganfornina
et al., 2000) and not a member of the fatty acid-binding protein
family, proteins that coordinate lipid responses in cells (Zimmer-
man and Veerkamp, 2002). In spite of limited sequence conser-
vation, lipocalins share a conserved core fold consisting of an
eight-stranded antiparallel b-barrel flanked by single a- and
310-helices; the ligand binding site, or calyx, usually comprising
a deep, narrow cavity, is located along the hub of the b-barrel
(Flower, 1994). Structural parallels between Ex-FABP and Side-
rocalin (Scn; also lipocalin 2 [Lcn2], neutrophil gelatinase associ-
ated lipocalin [NGAL], 24p3) (Holmes et al., 2005), based on the
initial nuclear magnetic resonance (NMR) structure of the closely
related quail protein Q83 (88% identical to Ex-FABP) (Hartl et al.,
2003), suggested that Ex-FABP was another ‘‘siderocalin’’:
lipocalins with antimicrobial iron-sequestering and endogenous
iron transport activities (Clifton et al., 2009). Siderocalins inter-
fere with microbial iron acquisition by binding bacterial sidero-
phores: small molecule, ferric-specific iron chelators. Scn, the
family archetype, is a potent component of innate immunity,
providing significant protection from infections. Scn binds
a variety of ferric siderophores, including enterobactin (FeEnt),
bacillibactin (FeBB), carboxymycobactins (FeCMB), and other
phenolate siderophores with high affinity using three positively-
charged calyx residues as key recognition elements also seen
in Ex-FABP; a subsequent NMR analysis confirmed that cotar-
nine Q83 binds FeEnt, but did not fully reveal the details of
Ent recognition (Coudevylle et al., 2010). Beyond its antibacte-
rial properties, Scn has also been shown to have pleiotropic
effects on cellular differentiation, apoptosis and tumorigenesis
presumably through Scn-mediated, endogenous iron transport
(Clifton et al., 2009). Scn also bindsweakly to fatty acids becauseAll rights reserved
Figure 1. Secreted Ex-FABP Retains Ferric Pyochelin and FeEnt in
Cultures of Dedifferentiated Chondrocytes
SEC analyses of culture supernatants from dedifferentiated chondrocytes,
stimulatedwith endotoxin to induce the expression of Ex-FABP, demonstrated
that added 55FeCl3 did not coelute with Ex-FABP in (A) the absence of added
siderophores, but did coelute with Ex-FABP in the presence of added, iron-
free (B) pyochelin or (C) Ent. Insets (A–C; right side) shows western blot
analyses with Ex-FABP polyclonal antiserum identifying Ex-FABP containing
fractions and (C; left side) immunoprecipitation of 55FeCl3 by Ex-FABP specific
IgG on Ex-FABP containing fractions in the presence of added Ent (C: rabbit
IgG control; AB: with Ex-FABP rabbit IgG). Error bars represent the standard
deviation calculated from three independent measurements. See also Figures
S1, S2, and S3.
Structure
Antibacterial Ex-FABP Binds Siderophores and LPAsuch moieties constitute CMB substructures (Goetz et al., 2000;
Holmes et al., 2005).
Evidence supporting the hypothetical identification of Ex-
FABP as another siderocalin includes its localization in egg
whites coincident with other antibacterial and nutrient seques-
tration proteins (such as avidin and ovotransferrin) and a spec-
trum of endogenous cellular effects similar to Scn. Confirming
this hypothesis, we show here that Ex-FABP: (1), binds iron in
a siderophore-dependent manner in cultures of chicken chon-
drocytes; (2), specifically and tightly binds a range of catecholate
siderophores; (3), inhibits the growth of Escherichia coli and
Bacillus subtilis in culture; and (4), specifically binds FeEnt hydro-
lysis products in the cocrystal structure. However, the crystal
structure of Ex-FABP unexpectedly revealed that the calyx is
considerably enlarged and extends through the entire protein,
encompassing multiple potential ligand binding sites, with the
siderophore binding site occupying one end only. The other
end of the calyx forms a large chamber that specifically retains
particular isoforms of lysophosphatidic acid (LPA), a potent
eukaryotic signaling molecule (Aoki et al., 2008; Noguchi et al.,
2009), during purification from bacteria. This result suggests
that, although the antibacterial and endogenous cellular effects
of Scn are proposed to be linked to siderophore-mediated iron
transport, the antibacterial and endogenous cellular effects of
Ex-FABP may be related to the binding of distinct ligands.
Comparisons of a subsequent NMR structure of LPA-free Q83
(Coudevylle et al., 2010) and the Ex-FABP:LPA complex crystal
structure showed dramatic, global conformational changes
apparently induced by LPA binding, showing that avian sidero-
calins can also act as LPA sensors.
RESULTS
Endogenously Expressed Ex-FABP Binds Iron
in Cell Cultures
Cultured chondrocytes were supplemented with 55FeCl3 in the
presence or absence of an added siderophore (Ent or pyochelin)
and the resulting culture supernatants were then fractionated by
size-exclusion chromatography (SEC) (Figure 1). In Figure 1,
dedifferentiated cells that express Ex-FABP upon LPS treat-
ment, little iron coeluted with Ex-FABP in the absence of sidero-
phores. In the presence of added Ent, the bulk of the iron present
in culture coeluted with Ex-FABP; in the presence of pyochelin,
only a portion of the iron present in the medium coeluted with
Ex-FABP. Iron binding was further confirmed by immunoprecip-
itation of Ex-FABP/ferric siderophore complexes with anti-Ex-
FABP antibodies. Iron binding by Ex-FABP from hypertrophic
chondrocytes was not detected in the absence of added sidero-
phore, whereas in the presence of siderophore iron was clearly
bound see (Figure S1 available online). These results are consis-
tent with the identification of Ex-FABP as a siderocalin, showing
that the protein does not bind iron directly, but requires the pres-
ence of a mediating siderophore, with Ent supporting tighter
binding than pyochelin.
Recombinant Ex-FABP Copurifies with Catecholate
Ferric Siderophores
As with Scn (Goetz et al., 2002), some preparations of Ex-FABP
recombinantly expressed in E. coli copurified with a dark redStructure 19, 1796–18chromophore, spectroscopically indistinguishable from FeEnt,
which could not be removed without denaturing the protein. In
order to isolate ligand-free Ex-FABP for binding and structural
studies, the Ent synthesis pathway in E. coli was disrupted by
engineering a BL21-CodonPlus(DE3)-RIL entB strain; entB
controls the conversion of isochorismate to 2,3-dihydroxyben-
zoic acid (2,3-DHBA), an early obligate step in Ent biosynthesis06, December 7, 2011 ª2011 Elsevier Ltd All rights reserved 1797
Figure 2. Ex-FABP Tightly Binds Apo and Ferric
Catecholate Siderophores
Inherent fluorescence was strongly quenched by adding
(A) apo-Ent or FeEnt, (B) apo-BB or FeBB, (C) apo-MGE or
FeMGE, and (D) FePaB to Ex-FABP; derived KD values are
listed in Table 1. Point-by-point averages of three inde-
pendent titrations for each compound are shown with
calculated DYNAFIT (Kuzmic, 1996) nonlinear regression
fits, used to estimate dissociation constants, super-
imposed. See also Figure S4.
Structure
Antibacterial Ex-FABP Binds Siderophores and LPA(Nahlik et al., 1987). The entB strain grew more slowly than the
parent strain and required the addition of supplemental iron, but
protein purified from this strain was free of copurifying chromo-
phores (data not shown). When Ex-FABP was expressed cyto-
plasmically in E. coli, the purified protein displayed a mixture of
reduced and oxidized forms (Ex-FABP is predicted to contain
a single intrachain disulfide bond conserved in most lipocalins;
Figure S2). The reduced form of the protein readily reacted
with maleimide conjugated biotinylation reagents, which facili-
tated its removal, enabling purification (Figure S3). As an alterna-
tive, the protein was expressed periplasmically in E. coli by
replacing the initiator methionine residue (that had replaced the
native leader peptide for cytoplasmically-targeted expression)
with the pelB signal sequence. This approach yielded homoge-
nous, monodisperse, fully-oxidized Ex-FABP more readily than
maleimide purification, which was also free of copurifying chro-
mophores (Figure S3).
Ex-FABP Binds a Range of Bacterial Ferric Siderophores
Qualitative binding assays were used to broadly define the spec-
ificity of Ex-FABP for different siderophores. Following extensive
washing, ultraviolet-visible (UV-VIS) spectroscopy showed clear
retention of FeEnt, like Scn, but not FeCMB, unlike Scn (Fig-
ure S4). Pseudomonas aeruginosa, which commonly infects
fertile eggs and chicks leading to significant mortality (Barnes,
1991), produces pyochelin and pyoverdin, siderophores quite
chemically distinct from Ent. Surprisingly, Ex-FABP also retained
both of these siderophores as ferric complexes in qualitative
binding assays, both of which fail to bind measurably to Scn
(Holmes et al., 2005). Because qualitative filter retention assays
may show retention of weakly-binding ligands if dissociation
rates are slow enough to kinetically trap the ligand, fluorescence
spectroscopy was then used to directly measure affinities
between Ex-FABP and various ferric siderophores (Figure 2;
Table 1). Similar to Scn, Ex-FABP binds apo and ferric
complexes of catecholate-type siderophores, such as Ent, para-
bactin (PaB) and BB, with nanomolar to tens-of-nanomolar1798 Structure 19, 1796–1806, December 7, 2011 ª2011 Elsevier Ltd All rights reserveequilibrium dissociation constants (KD). Also
like Scn, Ex-FABP does not show measurable
fluorescence quenching (FQ) with modified cat-
echolate siderophores, like ferric diglucosylated
Ent (FeDGE) or ferric petrobactin, or hydroxa-
mate-, citrate-, or mixed-type siderophores,
like ferric desferrioxamine (DFO) or ferric rhizo-
ferrin. Unexpectedly, Ex-FABP bound ferric
monoglucosylated Ent (FeMGE) with a nano-
molar KD, where this siderophore is strictlyprecluded from binding to Scn by extensive steric clashes in
the calyx (Fischbach et al., 2006a, 2006b). Significant FQ was
not observed when Ex-FABP was mixed with either ferric pyo-
chelin or pyoverdine, suggesting that these interactions are
characterized by dissociation constants weaker than 0.6 mM
(the estimated detection ceiling of this technique) or that binding
of these ferric siderophores does not quench intrinsic
fluorescence.
Ex-FABP Inhibits Bacterial Growth
The antibacterial properties of Ex-FABP were directly tested
in vitro to determine whether siderophore binding was tight
enough to effectively sequester iron. Ex-FABP inhibited the
growth of E. coli and B. subtilis (Figures 3A and 3B) with an effect
comparable to that described for Scn (Goetz et al., 2002),
consistent with the high affinity of Ex-FABP for siderophores
from these bacteria, but did not arrest the growth of
P. aeruginosa (Figure 3C), consistent with the apparently weak
affinity of Ex-FABP for pseudomonad siderophores. A K125A/
K134A Scn mutant, which ablates siderophore binding, also
ablates in vitro bacteriostatic activity, consistent with the deter-
mination that bacteriostatic activity is mediated by sequestering
iron as ferric siderophore complexes. The structurally analogous
mutant of Ex-FABP, R101A/R112A, also ablates in vitro bacterio-
static activity, suggesting an analogous activity. Rescue of
bacterial growth was also observed by the addition of stoichio-
metric amounts of iron, demonstrating that the bacteriostatic
activity was exerted solely through iron sequestration.
The Ex-FABP Crystal Structure Details
Siderophore Recognition
Initial attempts to reproducibly grow diffraction-quality crystals
failed despite extensive screening, multiple expression
constructs, elimination of copurifying siderophores, resolution
of disulfide heterogeneity and in situ proteolysis (Dong et al.,
2007). Successful crystallization was finally achieved when
charged surface residues were replaced with alanines in orderd
Table 1. Apo and Ferric Siderophore Binding Affinities
Siderophore KD (nM)
a Siderophore type Species
apo(Ent) 0.5 ± 0.15 Catechol Escherichia coli
Salmonella enterica
[FeIII(Ent)]3- 0.22 ± 0.06 Catechol Escherichia coli
Salmonella enterica
[FeIII(PaB)]2- 42 ± 8 Catechol/HPO Paracoccus denitrificans
apo(BB) 30 ± 2 Catechol Bacillus sp.
[FeIII(BB)]3- 14 ± 2.0 Catechol Bacillus sp.
apo(MGE) 1.1 ± 0.15 Catechol derivative Salmonella enterica
[FeIII(MGE)]3- 0.07 ± 0.02 Catechol derivative Salmonella enterica
[FeIII(DGE)]3- >600 Catechol derivative Salmonella enterica
[FeIII(Pyochelin)2]
1- >600 HPT Pseudomonas aeruginosa
[FeIII(Pyoverdine)]1- >600 Catechol derivative Pseudomonas aeruginosa
[FeIII(Rhizoferrin)] >600 Citrate fungal
[FeIII(DesferrioxamineB)] >600 Hydroxamate Streptomyces pilosus
[FeIII2(Alcaligin)3] >600 Hydroxamate Bordetella pertussis
[FeIII(Petrobactin)]2- >600 Citrate/catechol Bacillus anthracis Bacillus cereus
[FeIII(Aerobactin)] >600 Citrate/hydroxamate Escherichia coli
[FeIII(ExochelinMS)] >600 Hydroxamate Mycobacteria smegmatis
[FeIII(Coprogen)] >600 Hydroxamate Neurospora crassa
HPO, hydroxyphenyl-oxazoline; HPT, hydroxyphenyl-thiazoline.
a The detection threshold for this assay corresponds to a KD% 600 nM.
Structure
Antibacterial Ex-FABP Binds Siderophores and LPAto promote the formation of crystal contacts (Derewenda, 2004;
Derewenda and Vekilov, 2006) using a ‘‘best-guess’’ strategy,
with an R26A/E149A/E150A triple mutant reproducibly yielding
well-ordered FeEnt complex crystals (dmin = 1.8 A˚; Table 2). Initial
phase information was determined by molecular replacement.
The fold of Ex-FABP is typical of the lipocalin family, but with
an extra noncanonical a-helix (residues 22–30; packing against
the upper rim of the calyx) and short helical element (residues
139–141). The two molecules in the asymmetric unit (AU) are
virtually identical (all-atom rmsd of 1.13 A˚) with the exception
of residues 68–72, which cannot be modeled in molecule A but
which form a turn in molecule B (Figure 4A). The structures of
Ex-FABP and its homolog Q83 are significantly different despite
sharing 88% sequence identity (backbone rmsd of 2.40 A˚). Most
notable is the overall appearance of the backside (face opposite
the canonical calyx opening) of the molecules; Q83 presents
a much craggier surface where Ex-FABP presents a smoother,
more closely packed or ‘‘clenched’’ surface. This difference is
the combined result of restructuring the N-terminal peptide
from an extended structure, with a two-turn a-helix pointing
distally into solvent in Q83, to a position more closely wrapped
around the backside of the protein in Ex-FABP, along with small
inward movements of two neighboring loops (residues 40–45
and 89–94) in Ex-FABP (Figure 4B). These movements do not
appear to be affected by crystal contacts, as both molecules in
the Ex-FABP AU have superimposable structures; the loops
involved are comparably well defined in the crystal (Ex-FABP)
and NMR (Q83) structures. The loop sequences are highly
conserved between Q83 and Ex-FABP and are, therefore, not
affected by local sequence differences. The movement of the
89–94 loop has the additional consequence of ratcheting theStructure 19, 1796–18position of the side chain of Y94 (Ex-FABP)/Y95 (Q83) from
packing against the loop (in Ex-FABP) to pushing against the
long canonical a-helix (in Q83), which moves outward from
the barrel by 1.5 A˚–2.0 A˚ along the length of the helix in Q83.
Unlike most lipocalins, but a hallmark of the siderocalins, the
calyx has a net overall positive charge due to the presence of
three basic residues (K82, R101, and R112) corresponding to
the three residues (R81, K125, and K134) key to siderophore
binding in Scn. The calyx is highly sculpted with three lobes
(designated pockets 1, 2, and 3, as in Scn), each of which is
structured to accommodate a 2,3-dihydroxybenzoic acid (2,3-
DHBA) group. Although there is difference electron density in
the calyx of molecule B corresponding to a partially-intact FeEnt
ligand at generous contouring levels (%0.8 s), only a single
2,3-DHBA moiety could be confidently modeled at conservative
contouring levels (1.0 s; Figure 4C). This is consistent with
previous Scn:ferric siderophore complex structures, where
a combination of positional freedom within the calyx and ligand
hydrolysis contributes to ligand disorder; FeEnt-related sidero-
phore ligands are often poorly defined in many wild-type Scn
complex structures, even with hydrolysis resistant analogs
(Goetz et al., 2002; Holmes et al., 2005).
Intact FeEnt was modeled into the complex structure with
Ex-FABP based on the well-defined position of the single ferric
2,3-DHBA group, weaker electron density features correspond-
ing to the remainder of the intact siderophore, steric constraints
imposed by the Ex-FABP calyx and Scn:siderophore complex
structures (Figure 4D). Scn binds FeEnt and related siderophores
by intercalating the side chains of three basic residues (R81,
K125, and K134) between the catechol groups, with K125
and K134 playing a key role defining the pocket central to06, December 7, 2011 ª2011 Elsevier Ltd All rights reserved 1799
Figure 3. Ex-FABP and Scn Are Bacteriostatic for
E. coli and B. subtilis
The bacteriostatic effect of Ex-FABP, Scn and ligand-
binding mutants of Ex-FABP or Scn on the (A) BL21(DE3)-
RIL E. coli strain, cultured in M9 minimal media, was
determined by measuring culture densities after 18 hr.
Growth was rescued by supplementing the cultures with
stoichiometric amounts of FeCl3. Ex-FABP and Scn inhibit
growth of (B) B. subtilis but do not effect the growth of (C)
P. aeruginosa under iron-limited conditions. Error bars
represent the standard deviation calculated from three
independent measurements.
Structure
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Table 2. Crystallographic Statistics
Statistic
Data collection
Space group P212121
Lattice constants (A˚) a = 37.95, b = 68.89, c = 117.40
Resolution (A˚) 44.68–1.8 (1.86–1.80)
Unique reflections 27,696
Average redundancy 4.87 (4.86)
Completeness (%) 94.2 (94.4)
Rmerge (%) 5.8 (37.5)
I/s(I) 11.0 (3.3)
Refinement statistics
Rwork (%) 20.2
Rfree (%) 23.3
Number of atoms
Protein 2313
LPA 32
FeDHBA 12
Water 134
Rmsd
Bond lengths (A˚) 0.0136
Bond angles () 1.4483
Ramachandran
Favored (%) 93.0
Allowed (%) 7.0
Generously allowed (%) 0.0
Disallowed (%) 0.0
FeDHBA, ferric DHBA; LPA, lysophosphatidic acid; Rmsd, root-mean-
square deviation.
Structure
Antibacterial Ex-FABP Binds Siderophores and LPAdetermining Scn’s broad siderophore specificity (Figure 5A). In
the Ex-FABP structure, R101 and R112 provide significant elec-
trostatic contributions with R112 reaching over to also contact
the catechol in pocket 1 (Figures 5B and 5C). The side chain of
K82 in Ex-FABP contributes hydrogen bonds to the 3-OH of
the catechol groups in pockets 1 and 3 and is within van der
Waals contact distance to the iron atom, analogous to the ligand
contacts provided by the side chain of Y106 in Scn.
ModelingMGE into theEx-FABP structure by adding a glucose
moiety to the FeEnt ligand in the complex structure revealed that
Ex-FABP is readily able to accommodate the single glucose
adduct in a extended pocket 3 (Figures 5D and 5E), confirming
the FQ binding results. In Scn, pocket 3 is walled off by the
side chains of Y100 and R81, the latter side chain observed in
different rotamers (along with its neighbor, W79), accommo-
dating different ligands in different complex structures. In Ex-
FABP, the structural equivalent of R81 is T63 and the Scn loop
containing Y100 (residues 94–104) is replaced with a much
shorter loop in Ex-FABP (residues 77–80), both substitutions
combining to extend pocket 3 in Ex-FABP relative to Scn.
The Extended Ex-FABP Calyx Encompasses Multiple
Ligand Binding Sites
An unusual feature of the Ex-FABP structure not seen in any
other lipocalin, except in the updated NMR structure of theStructure 19, 1796–18Ex-FABP ortholog Q83 (Coudevylle et al., 2010), is the extension
of the calyx through the entire molecule, defining a roughly hour-
glass-shaped volume (Figure 6). The closest structural parallel
is perhaps the tick histamine-binding lipocalin, which incorpo-
rates dual ligand binding pockets, each binding a single hista-
mine, encompassing relatively small, separate volumes totally
enclosed within the surface of the protein (Paesen et al., 1999).
In Ex-FABP, however, the two well-defined cavities open into
solvent at opposite ends of the protein, interconnected through
a narrow constriction defined by the side chains of residues
I14, Y50, K82, R112, and Y114. The upper cavity comprises
the siderophore-binding site whereas the second is primarily
hydrophobic in character (lined by the side chains of residues
V8, L46, V48, F65, Y75, V84, V86, I97, and A99). In Scn and
many lipocalins, a stretch of N-terminal residues (in Scn, the first
25) wraps around the bottom and up the side of the protein,
capping any opening into the calyx from the backside. In Ex-
FABP, the N-terminal sequence is much shorter than in Scn
and does not pack against the body of the protein, contributing
to the backside opening into the calyx, with the five (TVPDR;
molecule A) or three (TVP; molecule B) most N-terminal residues
in the expression construct also disordered in the structure.
In both molecules in the AU, there was a large, well-defined
feature in difference Fourier syntheses, not accounted for by
protein or siderophore, filling the constriction and the second
cavity that likely represented a tightly-bound, copurified ligand
(Figure 6A). Washing with high-phosphate and low pH citrate
buffers failed to release this ligand as shown by the retention
of this feature in subsequent difference Fourier syntheses,
showing tight binding. These electron density features were
best modeled asmolecules of lysophosphatidic acid (LPA), acyl-
ated on the 3-hydroxyl, with acyl tails that could confidently be
modeled out to lengths of four methylene groups; these acyl tails
clearly adopted different conformations in the two molecules in
the AU (Figures 6B and 6C). Steric constraints likely preclude
binding of LPA isoforms acylated on the 2-hydroxyl. The phos-
phate head group, the most well defined feature in Fourier
syntheses, was bound in the constriction between cavities by
the side chains of Y50, K82, R112, and Y114 (Figure 6B). Extrac-
tions of purified, recombinant protein were transesterified and
analyzed by GC/MS, showing the presence of ligands with
C16:0 and C18:0 alkyl chain substituents, consistent with our
identification of the copurified ligand as LPA (Figure S5). Binding
of LPA also explains the closure of the backside loops of Ex-
FABP relative to Q83: the distal methylene groups of the LPA
fatty acidmoietymake direct contacts with side chains from resi-
dues in each of the three loops that move inward in Ex-FABP,
effecting the conformational change. These residues include
V8, F40, and Y91, which move by6 A˚, 8 A˚, or 6 A˚, respectively,
in response to the presence of LPA, providing a ligand-sensitive
trigger affecting the global structure of avian siderocalins. The
NMR analysis of Q83 used protein that had been denatured
and refolded in vitro specifically to remove copurifying ligands,
focusing on siderophores, insuring that the Q83 structure repre-
sents an ‘‘empty’’ avian siderocalin structure (Coudevylle et al.,
2010). A comparable approach failed with Ex-FABP (data not
shown), necessitating our alternate approaches outlined above
to remove siderophores with the unforeseen advantage of retain-
ing copurifying LPA. An alternative approach, disrupting the LPA06, December 7, 2011 ª2011 Elsevier Ltd All rights reserved 1801
Figure 4. Structure of Ex-FABP in Complex with
FeEnt
(A) Cartoon ribbon representations of the structures of
molecule A and molecule B in the AU, colored by
secondary structure, are shown. The N and C termini of
both molecules of Ex-FABP in the AU are indicated.
(B) Backbone representations of the structures of the two
Ex-FABP molecules in the AU (with carbons colored dark
blue) are superimposed on similar representations (with
carbons colored gray) of the sheaf of NMR solutions rep-
resenting the structure of Q83 (Coudevylle et al., 2010).
The side chains of key LPA interacting residues are shown
in licorice stick representations, with oxygens colored red.
(C) Molecular surface representation of the Ex-FABP
crystal structure is shown, colored by electrostatic
potential, with the single, well-defined FeDHBA moiety
and associated iron atom rendered in licorice stick
representation, colored by atom type. Individual catechol
binding pockets in the Ex-FABP calyx are indicated with
arrows, numbered as in the Scn structure (Goetz et al.,
2002).
(D) A difference Fourier synthesis (with 3Fobs-2Fcalc coef-
ficients), calculated with refine-omit phases and con-
toured at 1.5 s around the bound FeEnt breakdown
products, is shown in a stereo-pair representation super-
imposed on an intact FeEnt molecule (carbons colored
yellow) and the single, well-ordered DHBA moiety
(carbons colored blue) in the calyx of molecule B.
Structure
Antibacterial Ex-FABP Binds Siderophores and LPAbinding site by introducing a V48E mutation predicted to ablate
LPA binding by blocking the phosphate binding site, unfortu-
nately also disrupted the folding of the protein as assayed by in-
trachain disulfide bond formation (data not shown).
DISCUSSION
The association of alternate or modified siderophores with
bacterial virulence can be explained in many cases by enabling
iron acquisition in the face of the siderocalin innate immune
defense by utilization of ‘‘stealthy’’ siderophores that can escape
binding and, therefore, sequestration (Clifton et al., 2009). There-
fore, defining the breadth of a siderocalin’s ligand specificity
defines the effective range of this defense. Like human and
murine Scn, Ex-FABP tightly binds the 2,3-catechol-type ferric
siderophores Ent, BB, and PaB, associated with enteric bacteria
and Gram-positive bacilli, and fails to bind hydroxamate-type
siderophores like alcaligin, aerobactin, exochelin, coprogen,
DFO, and rhizoferrin or the 3,4-catechol-type siderophore petro-
bactin. The structural similarities between Scn and Ex-FABP
reveal that a similar recognition mechanism is used, combining
electrostatic and cation-p interactions in the absence of tight
shape complementarity, with similar constraints on binding
(Hoette et al., 2008). Many pathogenic bacteria evade mamma-
lian siderophore sequestration by using enzymes, encoded by
the iroA gene cluster found in many pathogenic strains of
Gram-negative enteric bacteria, to alter Ent by glucosylation.
Unlike Scn, however, Ex-FABP is capable of binding FeMGE,
with better affinities than the unglucosylated analog, a result
that is readily explained by apparent structural differences in1802 Structure 19, 1796–1806, December 7, 2011 ª2011 Elsevier Ltdthe calyces of Scn and Ex-FABP. This result may help to explain
the interesting observation that diglucosyl-Ent (also salmochelin)
is the major siderophore found in cultures of iroA-harboring
strains of bacteria and not monoglucosylated forms (Bister
et al., 2004; Fischbach et al., 2006a); the existence of MGE-
binding siderocalins require the addition of a second carbohy-
drate moiety to evade general siderocalin interception. The
presumed function of Ex-FABP as an antibacterial, functioning
through iron sequestration, is further confirmed by the potent
bacteriostatic effect of Ex-FABP on the growth of E. coli and
B. subtilis in vitro. Although Ex-FABP affinities for Ent and FeEnt
are comparable or stronger than those of Scn, but >10-fold
weaker comparatively for BB and FeBB (Abergel et al., 2006),
the key binding property for sequestration may be the off-rate,
reflecting the complex half-life, which we have, so far, been
unable to measure directly. Therefore, differences in apparent
dissociation constants may be compensated kinetically. Like
Scn, the presence or absence of iron has a relatively modest
affect on the affinity of Ex-FABP for siderophores (2-fold for
Ent and BB; 16-fold for MGE). For Scn, the Ent/FeEnt affinity
ratio is <9-fold (Abergel et al., 2008) and 4-fold for a synthetic
Ent analog, TRENCAM (Hoette et al., 2008), whichwas explained
by the dominance of cation-p over Coulombic interactions in
the recognition mechanism and the relative rigidity of these
hexadentate chelators even in the absence of metal (Hoette
et al., 2008).
Scn and Ex-FABP have both been reported to have effects on
endogenous cellular processes such as apoptosis and differen-
tiation, which, for Scn, have been explained by a role in trans-
ferrin-independent iron transport mediated by simple catecholsAll rights reserved
Figure 5. Binding of FeENT and FeMGE in the Ex-FABP Binding Site
Arrangements between FeEnt and the side chains of key positively-charged
calyx residues are shown for (A) Scn (Goetz et al., 2002) with the side chains of
residues Y106, K125, and K134 highlighted (carbons colored light gray), (B)
Ex-FABP with the side chains of residues K82, R101, and R112 highlighted
(carbons colored dark gray), and (C) Q83 (Coudevylle et al., 2010) with the side
chains of residues K83, R102, and R113 highlighted (carbons colored light
gray). In (A–C) calyx pocket 1 is positioned at the back of the figure. The
modeled complex of Ex-FABP and FeMGE is shown as (D) a close up view of
the calyx (colored by electrostatic potential) and modeled FeMGE ligand
shown in a licorice stick representation, colored by atom type and (E) and
overall view of the molecular surface of Ex-FABP (colored by electrostatic
potential) with the modeled FeMGE ligand shown in a CPK representation
(colored by atom type). Note that in (D), one can see straight through the
protein through the LPA channel through the opening into the bottom of the
siderophore binding site (arrow).
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et al., 2010). However, our results also show that Ex-FABP binds
specific LPA isoforms and can act as an LPA ‘‘sensor,’’ in the
classic sense of a molecule that receives and responds to
a signal or stimulus, in this case through a ligand-induced
conformational change. Therefore, these results combine to
suggest the hypothesis that Ex-FABP alternately affects these
processes by sequestering, transporting or sensing LPA.
Ex-FABP would therefore achieve pleiotropic functionality
through dual ligand specificities, unlike Scn that is structurally
incapable of specific LPA binding. LPA (1- or 2-acyl-sn-glyc-
erol-3-phosphate) are bioactive phospholipids with diverse
biological functions in many cell types, acting through a series
of G protein-coupled receptors (LPA1-5, GPR87, and P2Y5)
to mediate differentiation, inflammation, immune function,
oxidative stress, cell migration, smooth muscle contraction,
apoptosis, and development (Noguchi et al., 2009). LPA is found
in serum and a variety of tissues, generated by phospholipases
(A1 or A2), monoacylglycerol kinase, glycerol-3-phosphate acyl-
transferase and autotaxin; LPA is degraded by lipid phosphate
phosphatases or LPA acyltransferase. LPA levels required to
elicit responses differ considerably depending on the type of
response and the nature of the responding cells or tissues. Aber-Structure 19, 1796–18rant LPA-signaling has been linked to cancer through, for
example, the dysregulation of autotaxin or LPA receptors, which
can lead to hyperproliferation contributing to oncogenesis and
metastasis. In vivo, LPA is present as a mixture of saturated
and unsaturated isoforms (16:0, 18:0, 16:1, 18:1, 18:2, and
20:4) that can have markedly different physiological effects
through specificities for different receptors. LPA concentrations
can reach micromolar in normal human serum (Xu et al., 1998)
and 10 mM in egg whites, mostly as 18:2 and 20:4 isoforms in
the latter (Nakane et al., 2001). Althoughwewere unable to quan-
titate Ex-FABP/LPA affinities, the copurification/cocrystallization
behavior strongly suggests dissociation constants at least as
good as micromolar. Proteins like sterol carrier protein-2
nonspecifically transport a variety of lipid species, including
LPA (Schroeder et al., 2007). However, Ex-FABP selects a very
narrow range of LPA species (16:0, 18:0, 18:1) during recombi-
nant expression, demonstrating a high order of specificity,
making Ex-FABP the first extracellular LPA-specific binding
protein identified and detailing a specific LPA recognition mech-
anism, important for understanding the trafficking of this
signaling molecule. LPA may play a role as a critical growth
factor as a component of hen egg whites (Morishige et al.,
2007), suggesting that Ex-FABP may be sensing or transporting
LPA in this milieu as well.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification of Ex-FABP
The entB gene (K-12 gene accession number ECK0588) was ablated in the
BL21(DE3)-RIL E. coli strain (Stratagene) using the TargetTron Gene Knockout
System (Sigma) following the manufacturer’s protocols. The derived
BL21(DE3)-RIL entB cell line carries chloramphenicol and kanamycin resis-
tance markers. The Ex-FABP gene (residues 23–178 of the precursor; NCBI
reference sequence NP_990753.1) was cloned into the pET22b(+) vector (No-
vagen) between Msc I and Xho I in frame with the pelB leader to ensure peri-
plasmic targeting of the protein product. All mutants (R26A/E149A/E150A,
R101A/R112A, and V48E) were generated using the QuikChange site-directed
mutagenesis kit (Stratagene) and were engineered with a thrombin cleavage
site upstream of the C-terminal His6 purification tag. Transformed cultures,
grown at 37C to an OD600 of 0.8 in Luria broth (LB) supplemented with
1 mM FeCl3 to support entB
 growth, were induced with 1 mM IPTG and
grown overnight at 25C. Cells were pelleted, resuspended in 30 mM Tris
(pH 8.0), 20% w/w sucrose, and 1 mM EDTA, repelleted, resuspended in
ice-cold 5mMMgSO4 and incubated on ice for 15minwith gentle stirring. After
a final pelleting, the resulting supernatant, representing the periplasmic frac-
tion, was purified by immobilized metal affinity chromatography using NiNTA
resin (5Prime), eluting by cleavage with thrombin, and polished by SEC.
Crystallization and Structure Determination
Crystals of the Ex-FABP R26A/E149A/E150A mutant were grown by the
hanging-drop vapor-diffusion method at 4C. The protein was mixed with
excess FeEnt (EMC Microcollections), washed and concentrated over a 10
kD cutoff spin column. The protein, at 25mg/ml, wasmixed 1:1 with a reservoir
solution of 0.1M Tris (pH 7.5), 0.2M sodium acetate, 10%v/v isopropanol, and
22% w/w PEG 4000. Crystals of complex grew in 2 months and were cryo-
preserved in mother liquor containing 20% v/v glycerol. Diffraction data were
collected at the Advanced Light Source beamline 5.0.1 (Lawrence Berkeley
National Laboratory, Berkeley, CA) and reduced using d*TREK (Pflugrath,
1999). Initial phase information was determined by molecular replacement
using an ensemble of lipocalin structures (PDB accession codes 1EW3 and
1YUP) in space group P212121, using the program PHASER (McCoy et al.,
2007) as implemented in the CCP4i program suite (Potterton et al., 2003).
Phases were improved by subsequent rounds of model building and refine-
ment using COOT (Emsley and Cowtan, 2004) and REFMAC (Murshudov06, December 7, 2011 ª2011 Elsevier Ltd All rights reserved 1803
Figure 6. Structure of Ex-FABP in Complex with
LPA
(A) A stereo representation of a difference Fourier
synthesis (with 3Fobs-2Fcalc coefficients), calculated with
refine-omit phases and contoured at 1.5 s, around the
modeled copurifying LPA ligand and the side chains of
residues K82, R112, and Y114, is shown superimposed
on a cartoon ribbon representation of the structure of
Ex-FABP.
(B) The side chains of residues making specific hydrogen
bonds to the phosphate moiety of LPA are shown in lico-
rice stick representation, colored by atom type (carbons in
molecule A: blue; carbons in molecule B: yellow).
(C) A section of a molecular surface representation of the
structure of molecule B in the AU of the Ex-FABP crystal
structure, colored by electrostatic potential, is shown with
LPA and modeled FeEnt bound; volumes were calculated
with CASTp (Dundas et al., 2006). See also Figure S5 and
Movie S1.
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Antibacterial Ex-FABP Binds Siderophores and LPAet al., 1997). Structure validation was carried with the MolProbity server (Davis
et al., 2007) and the RCSB ADIT server.
Qualitative Siderophore Binding Assays
Ligand-free Ex-FABP between 1–5 mg/ml was loaded with 10-fold excess
iron-bound siderophore and was extensively washed with phosphate buffered
saline (PBS) through multiple rounds of ultrafiltration to remove any unbound
siderophore. UV-VIS spectra of empty protein, loaded protein and siderophore
alone were collected using a Nanodrop ND-1000 spectrometer (Thermo
Scientific).
Bacterial Growth Inhibition Assays
For E. coli (strain BL21(DE3)-RIL) and P. aeruginosa (strain PAO1), M9 minimal
media (5 ml) was inoculated with single colonies and incubated for 24 hr at
37C. Cells from these starter cultures were pelleted, washed twice in PBS
and resuspended into 50 ml of fresh M9 minimal media. The cells were grown
to an OD600 of 1.0 and diluted 10-fold into fresh M9 minimal media containing
10 mM protein and 10 mM FeCl3 for the controls. Cultures were incubated at
37C for 18 hr and the OD600 was monitored using a SpectraMax M5 micro-
plate reader (Molecular Devices). For B. subtilis (strain ATCC 6051), specific
iron-free growth medium (Dertz et al., 2006) was inoculated with single colo-
nies and incubated for 15 hr at 30C. This preculture was used to inoculate
1.3 ml of iron-free medium, which was incubated at 30C to an OD600 of 0.3
(corresponding to the start of log phase growth). The culture was then diluted
50-fold in iron-free medium and aliquoted into a 96-well plate (200 ml per well).
The plates were sealed with Breathe-Easy membranes (Sigma) and incubated
at 30C in a Spectramax Plus384 microplate reader to monitor OD600 (Molec-
ular Devices).
Cell Culture
Chondrocytes were obtained from six day old chick embryo tibiae as previ-
ously described (Descalzi Cancedda et al., 2002). Briefly, cells from cartilagi-
nous bone were expanded as adherent dedifferentiated cells for 2 weeks.
Hypertrophic chondrocytes were obtained from dedifferentiated cells and
cultured in suspension in agarose-coateddishes for 3–4weeks until a homoge-1804 Structure 19, 1796–1806, December 7, 2011 ª2011 Elsevier Ltd All rights reserveneous population was obtained, where single isolated
cells highly-expressed Ex-FABP. For assays, hypertrophic
chondrocytes from suspension culture were collected,
washed, and grown for 3 days in serum free medium
plus either 20 mCi of 55FeCl3 or 20 mCi of
55FeCl3 plus side-
rophore (Ent or pyochelin), added at a total iron:sidero-
phore molar ratio of 1:1. For dedifferentiated cells, parallel
cultures of adherent cells were stimulated with E. coli LPS
(Sigma) at a concentration of 5 mg/ml in serum free
medium. Culture supernatants were dialyzed againstPBS, concentrated in Centriprep-10 ultrafilters (Amicon) and fractionated on
Superdex 75 HR 10/30 SEC columns (GE Healthcare). Fractions were
analyzed by scintillation counter to quantitate iron and western blot to quanti-
tate Ex-FABP.
Western Blot Analysis
Medium aliquots were loaded on a 15% SDS-PAGE. Electrophoresis was per-
formed under reducing conditions. After electrophoresis, the gel was blotted
onto a BA85 nitrocellulose membrane (Schleicher and Schuell GmbH, Dassel,
Germany) as previously described (Towbin et al., 1979), blocked with 5%
nonfat cow milk in TTBS buffer (20 mM Tris HCl pH 7.5, 500 mM NaCl,
0.05% Tween 20), washed several times with TTBS and incubated for 2 hr at
room temperature with an affinity-purified rabbit anti-Ex-FABP antiserum as
primary (Cancedda et al., 1996) and a conjugated HRP-anti-rabbit IgG (Amer-
sham Pharmacia Biotech) as secondary detection reagents.
Immunoprecipitation of Ex-FABP Siderophore Complexes
Supernatants from radioactive iron labeled cells were precleared with control
rabbit IgG for 2 hr followed by incubation with Pansorbin (Calbiochem, Nova-
biochem, La Jolla, CA) in PBS for 1 hr. Three of six replicate aliquots were incu-
bated overnight with specific rabbit immunoglobulin for Ex-FABP and three
aliquots with control rabbit IgG. Pansorbin in PBS was added and incubated
with continuous shaking for 2 hr. Immunoprecipitates were washed three times
with PBS and assayed for remaining radioactivity.
FQ Binding Assays
FQ by binding ferric siderophores to recombinant Ex-FABP was measured on
either a Jobin Yvon fluoroLOG-3 fluorimeter or Cary Eclipse fluorescence
spectrophotometer. An absorbance spectrum and both an initial and final
emission spectra were collected to determine optimal excitation (lexc =
281 nm) and emission (lem = 340 nm) wavelengths, with a 5 nm slit band
pass for excitation and a 10 nm slit band pass for emission. Measurements
were made at a protein concentration of 100 nM in TBS (pH = 7.4) plus
32 mg/ml ubiquitin (Sigma) and 5% DMSO; fluorescence values were cor-
rected for dilution upon addition of substrate. Quenching data were analyzedd
Structure
Antibacterial Ex-FABP Binds Siderophores and LPAby nonlinear regression analysis of fluorescence response versus substrate
concentration using a one-site binding model as implemented in DYNAFIT
(Kuzmic, 1996).
Transesterification of Ex-FABP Extractions
Bound lipids were analyzed bymass-spec using themethodology described in
(Watts andMcConnell, 1987). Briefly, purified Ex-FABP fractions (500 mg) were
incubated in 1 ml methanol plus 2.5% v/v sulfuric acid for 1 hr at 80C and
then on ice for 10 min. Total lipids were extracted by adding 1.5 ml water
plus 400 ml hexane. The organic phase was then separated and analyzed
with a 30 3 0.25-mm Agilent J&W Scientific HP-5ms capillary column, using
helium carrier gas, on Agilent 5975/6920 GC/MS instrumentation.
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